• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Truveta Data used in largest, first-of-its-kind comparative study of medical devices for treatment of pulmonary embolism

Truveta Data used in largest, first-of-its-kind comparative study of medical devices for treatment of pulmonary embolism

by Truveta staff | Oct 24, 2023 | Research

Each year, approximately 900,000 patients in the United States are affected by PE, a blood clot causing a blockage in one or more pulmonary arteries in the lungs and a leading cause of in-hospital death in the U.S. Acute pulmonary embolism (PE) is the third-leading...

Share this


Recent posts

  • New study finds GLP-1 RA medications may significantly reduce risk of alcohol-related hospitalization
  • Understanding the impact of the COVID-19 pandemic on childhood MMR vaccination patterns
  • Shifting trends in TKA fixation: Real-world evidence on the changing landscape of cemented vs uncemented TKA

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice